A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Shanghai Bovax Biotechnology Co., Ltd.